Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-07

Clinical Trial Update: A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update for the ALPFA BPH PFA System in prostate cancer patients. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALPFA BPH PFA System

Snippet

Sponsor: ALPFA Medical | Conditions: Prostate Cancer | NA | Status: NOT_YET_RECRUITING